Altrius Capital Management Inc Lowers Stock Holdings in Cardinal Health, Inc. (NYSE:CAH)

Altrius Capital Management Inc lowered its holdings in Cardinal Health, Inc. (NYSE:CAH) by 2.5% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 43,897 shares of the company’s stock after selling 1,118 shares during the period. Altrius Capital Management Inc’s holdings in Cardinal Health were worth $5,192,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. grew its holdings in Cardinal Health by 35.2% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 32,520 shares of the company’s stock worth $3,871,000 after acquiring an additional 8,471 shares in the last quarter. CHURCHILL MANAGEMENT Corp grew its holdings in shares of Cardinal Health by 1.5% during the fourth quarter. CHURCHILL MANAGEMENT Corp now owns 240,422 shares of the company’s stock worth $28,435,000 after purchasing an additional 3,576 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of Cardinal Health by 0.7% in the 3rd quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company’s stock valued at $633,298,000 after purchasing an additional 42,082 shares during the last quarter. Consolidated Planning Corp boosted its position in shares of Cardinal Health by 40.0% in the 4th quarter. Consolidated Planning Corp now owns 8,926 shares of the company’s stock valued at $1,056,000 after purchasing an additional 2,552 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its stake in Cardinal Health by 2.3% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company’s stock worth $162,976,000 after buying an additional 33,388 shares during the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Up 0.0 %

NYSE:CAH opened at $127.22 on Friday. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $132.84. The firm has a market capitalization of $30.73 billion, a price-to-earnings ratio of 23.74, a PEG ratio of 1.49 and a beta of 0.63. The firm’s fifty day simple moving average is $124.52 and its 200 day simple moving average is $117.85.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. On average, analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 annualized dividend and a dividend yield of 1.59%. Cardinal Health’s payout ratio is 37.69%.

Analyst Ratings Changes

A number of equities research analysts have weighed in on CAH shares. Citigroup boosted their price objective on Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a research note on Friday, January 10th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Morgan Stanley boosted their price target on Cardinal Health from $136.00 to $142.00 and gave the company an “overweight” rating in a research report on Friday, January 31st. JPMorgan Chase & Co. lifted their target price on Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a research note on Tuesday, February 4th. Finally, Evercore ISI raised shares of Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price objective on the stock in a research note on Tuesday, January 7th. Four research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $139.36.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.